Bath & Body Works Investors Reminder for Class Action Lawsuit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy BBWI?
Source: Globenewswire
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36 on August 28, 2025, indicating a significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company reported a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, reflecting weak market performance and further eroding investor confidence.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, deciding to exit certain adjacencies and refocus on core categories, highlighting the need for a strategic reassessment for future growth.
- Legal Action: Investors are reminded to file a lead plaintiff motion by March 16, 2026, alleging that the company failed to disclose significant adverse facts about its business and prospects throughout the class period, potentially exposing investors to greater financial losses.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BBWI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BBWI
Wall Street analysts forecast BBWI stock price to rise
14 Analyst Rating
4 Buy
10 Hold
0 Sell
Moderate Buy
Current: 18.780
Low
15.00
Averages
20.14
High
26.00
Current: 18.780
Low
15.00
Averages
20.14
High
26.00
About BBWI
Bath & Body Works, Inc. is a global omnichannel retailer focused on personal care and home fragrance. The Company offers a range of fragrances for the body and home, including selling collections for 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions and body creams. It delivers customers their fragrances in multiple forms and categories. The Company sells merchandise through its retail stores in the United States and Canada, and through its Websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company’s international business is conducted through franchise, license and wholesale partners. It provides in-store experiences at more than 1,890 Company-operated Bath & Body Works locations in the United States and Canada, more than 525 international franchised locations and an online storefront at bathandbodyworks.com. Additionally, it offers a buy online pick-up in-store (BOPIS) option.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
House Committee Seeks Testimony from Epstein's Jail Guard
- Testimony Request: House Oversight Committee Chair James Comer has called for prison guard Tova Noel to testify on March 26, as she allegedly Googled Epstein minutes before his death, potentially providing crucial insights for the investigation.
- Investigation Context: Epstein was arrested in July 2019 on federal child sex trafficking charges and died by suicide weeks later in a New York federal jail; Noel was accused of failing to conduct routine checks and falsifying records, although charges were ultimately dropped.
- Impact of Transparency Act: Since the passage of the Epstein Files Transparency Act, the Department of Justice has released millions of documents related to Epstein, but failed to meet the deadline for full disclosure, leading to criticism over its handling of sensitive information.
- Political Figures Testimony: The committee has subpoenaed high-profile individuals like Bill and Hillary Clinton, all of whom have denied involvement in Epstein's illegal activities, highlighting the case's significant implications for the political landscape.
See More
Faruqi & Faruqi Investigates Bath & Body Works Securities Claims
- Legal Investigation Launched: Faruq & Faruq LLP is investigating potential securities fraud claims against Bath & Body Works (NYSE: BBWI), urging investors to contact them by March 16, 2026, to seek lead plaintiff status in a class action, thereby protecting their rights.
- Declining Financial Performance: On November 20, 2025, Bath & Body Works reported a 1% year-over-year decline in revenue for Q3, missing the 1-3% growth guidance, with net income plummeting 26% to $77 million, indicating a failure in the company's strategy.
- Strategic Missteps Revealed: The company acknowledged that its strategy of
See More
Bath & Body Works Securities Class Action Notice
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, to apply as lead plaintiffs by March 16, 2026, to potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially misleading statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked number one for securities class action settlements in 2017, demonstrating its strong capabilities in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in leadership roles to ensure effective legal support in class actions, avoiding firms that merely act as intermediaries.
See More
Bath & Body Works Investors Reminder for Class Action Lawsuit
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36 on August 28, 2025, indicating a significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company reported a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, reflecting weak market performance and further eroding investor confidence.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, deciding to exit certain adjacencies and refocus on core categories, highlighting the need for a strategic reassessment for future growth.
- Legal Action: Investors are reminded to file a lead plaintiff motion by March 16, 2026, alleging that the company failed to disclose significant adverse facts about its business and prospects throughout the class period, potentially exposing investors to greater financial losses.
See More
Class Action Notice for Bath & Body Works Investors
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, to apply as lead plaintiffs by March 16, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its successful track record in this field.
- Investor Guidance: Investors are advised to select counsel with a proven track record to ensure effective representation in the class action, avoiding firms that merely act as intermediaries without substantial litigation experience.
See More
Bath & Body Works Faces Class Action Lawsuit
- Lawsuit Background: Bragar Eagel & Squire has filed a class action lawsuit against Bath & Body Works in the Southern District of Ohio on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025, alleging failure to disclose critical financial information that led to investor losses.
- Financial Missteps: The complaint states that Bath & Body Works reported a 1% year-over-year revenue decline and a 26% drop in net income to $77 million in its Q3 2025 results released on November 20, 2025, failing to meet its growth guidance and indicating significant strategic execution failures.
- Stock Price Plunge: Following the disappointing financial results, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share, reflecting strong market concerns regarding the company's future growth prospects.
- Investor Action: Investors must apply by March 16, 2026, to be appointed as lead plaintiffs in the lawsuit to protect their legal rights, with Bragar Eagel & Squire offering free consultations to assist affected investors in understanding their rights and options.
See More
House Committee Seeks Testimony from Epstein's Jail Guard
- Testimony Request: House Oversight Committee Chair James Comer has called for prison guard Tova Noel to testify on March 26, as she allegedly Googled Epstein minutes before his death, potentially providing crucial insights for the investigation.
- Investigation Context: Epstein was arrested in July 2019 on federal child sex trafficking charges and died by suicide weeks later in a New York federal jail; Noel was accused of failing to conduct routine checks and falsifying records, although charges were ultimately dropped.
- Impact of Transparency Act: Since the passage of the Epstein Files Transparency Act, the Department of Justice has released millions of documents related to Epstein, but failed to meet the deadline for full disclosure, leading to criticism over its handling of sensitive information.
- Political Figures Testimony: The committee has subpoenaed high-profile individuals like Bill and Hillary Clinton, all of whom have denied involvement in Epstein's illegal activities, highlighting the case's significant implications for the political landscape.
See More
Faruqi & Faruqi Investigates Bath & Body Works Securities Claims
- Legal Investigation Launched: Faruq & Faruq LLP is investigating potential securities fraud claims against Bath & Body Works (NYSE: BBWI), urging investors to contact them by March 16, 2026, to seek lead plaintiff status in a class action, thereby protecting their rights.
- Declining Financial Performance: On November 20, 2025, Bath & Body Works reported a 1% year-over-year decline in revenue for Q3, missing the 1-3% growth guidance, with net income plummeting 26% to $77 million, indicating a failure in the company's strategy.
- Strategic Missteps Revealed: The company acknowledged that its strategy of
See More
Bath & Body Works Securities Class Action Notice
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, to apply as lead plaintiffs by March 16, 2026, to potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially misleading statements during the Class Period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked number one for securities class action settlements in 2017, demonstrating its strong capabilities in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in leadership roles to ensure effective legal support in class actions, avoiding firms that merely act as intermediaries.
See More
Bath & Body Works Investors Reminder for Class Action Lawsuit
- Earnings Miss: Bath & Body Works reported Q2 2025 earnings of $0.30 per share, a 55.8% year-over-year decline, missing prior guidance by $0.03, which led to a 6.9% drop in stock price to $29.36 on August 28, 2025, indicating a significant deterioration in profitability.
- Performance Decline: In Q3 2025, the company reported a 1% year-over-year revenue decline, failing to meet its growth guidance of 1-3%, with net income falling 26% to $77 million, reflecting weak market performance and further eroding investor confidence.
- Strategic Shift: The company acknowledged that its strategy of “adjacencies, collaborations, and promotions” failed to effectively grow its customer base, deciding to exit certain adjacencies and refocus on core categories, highlighting the need for a strategic reassessment for future growth.
- Legal Action: Investors are reminded to file a lead plaintiff motion by March 16, 2026, alleging that the company failed to disclose significant adverse facts about its business and prospects throughout the class period, potentially exposing investors to greater financial losses.
See More
Class Action Notice for Bath & Body Works Investors
- Class Action Notice: Rosen Law Firm reminds investors who purchased Bath & Body Works securities between June 4, 2024, and November 19, 2025, to apply as lead plaintiffs by March 16, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Bath & Body Works made materially false statements during the class period, failing to disclose that its strategy of 'adjacencies, collaborations, and promotions' was not effectively growing its customer base, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its successful track record in this field.
- Investor Guidance: Investors are advised to select counsel with a proven track record to ensure effective representation in the class action, avoiding firms that merely act as intermediaries without substantial litigation experience.
See More
Bath & Body Works Faces Class Action Lawsuit
- Lawsuit Background: Bragar Eagel & Squire has filed a class action lawsuit against Bath & Body Works in the Southern District of Ohio on behalf of investors who purchased securities between June 4, 2024, and November 19, 2025, alleging failure to disclose critical financial information that led to investor losses.
- Financial Missteps: The complaint states that Bath & Body Works reported a 1% year-over-year revenue decline and a 26% drop in net income to $77 million in its Q3 2025 results released on November 20, 2025, failing to meet its growth guidance and indicating significant strategic execution failures.
- Stock Price Plunge: Following the disappointing financial results, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share, reflecting strong market concerns regarding the company's future growth prospects.
- Investor Action: Investors must apply by March 16, 2026, to be appointed as lead plaintiffs in the lawsuit to protect their legal rights, with Bragar Eagel & Squire offering free consultations to assist affected investors in understanding their rights and options.
See More
